Narutoshi Hibino

Title: Innovations in Tissue Engineering by Narutoshi Hibino

Introduction

Narutoshi Hibino is a prominent inventor based in Towson, MD (US), known for his significant contributions to the field of tissue engineering. With a total of four patents to his name, Hibino has focused on optimizing patient-specific solutions in vascular graft technology. His work aims to enhance patient outcomes through innovative engineering methods.

Latest Patents

Hibino's latest patents revolve around systems and methods for optimized patient-specific tissue engineering vascular grafts. His research has established that optimizing cell seeding onto tissue engineering vascular grafts (TEVG) is associated with reduced inflammatory responses and decreased post-operative stenosis. The findings indicate that cell seeding increases TEVG patency in a dose-dependent manner, with improved outcomes when more cells are seeded. However, the duration of incubation time has shown minimal effect on TEVG patency. His patents provide methods for engineering patient-specific TEVG, including optimal cell numbers to maintain graft patency and reduce post-operative complications. Additionally, he has developed closed, single-use customizable systems for seeding TEVG, which are designed based on the morphology of the patient-specific graft to enhance the efficacy of cell seeding.

Career Highlights

Throughout his career, Narutoshi Hibino has worked at notable institutions, including the Research Institute at Nationwide Children's Hospital and Children's National Medical Center. His experience in these organizations has contributed to his expertise in tissue engineering and patient-specific solutions.

Collaborations

Hibino has collaborated with esteemed colleagues, including Christopher K. Breuer and Cameron Best, to advance the field of tissue engineering. Their joint efforts have led to innovative approaches in developing effective vascular grafts.

Conclusion

Narutoshi Hibino's work in tissue engineering, particularly in optimizing patient-specific vascular grafts, showcases his commitment to improving healthcare outcomes. His innovative patents and collaborations highlight the importance of research in advancing medical technology.